| 000 | 04494nam a22004095i 4500 | ||
|---|---|---|---|
| 001 | 84930 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040447.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 151130s2016 gw | s |||| 0|eng d | ||
| 020 | _a9783319234588 | ||
| 040 | _aES-MaUEC | ||
| 050 | 4 |
_aRC902 _b2016 EB |
|
| 082 | 0 | 4 | _a616.61 |
| 100 | 1 |
_aRayner, Hugh. _997512 _0Local |
|
| 245 | 1 | 0 |
_aUnderstanding Kidney Diseases _cby Hugh Rayner, Mark Thomas, David Milford |
| 250 | _a1st ed. | ||
| 260 |
_aCham _bSpringer International Publishing _c2016 |
||
| 300 |
_a1 recurso en línea (XXI, 300 páginas) _b216 ilustraciones, 81 ilustraciones en color |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 505 | 0 | _aIntroduction -- The purpose of the book � understanding the natural history of kidney disease -- how displaying a GFR history is a fundamental part of the clinical assessment of kidney diseases -- how the eGFR graph is used to inform patients and plan treatment.-principles but not details of treatment -- The basics of creatinine measurement and eGFR equations in adults -- Simple guide to the classification of AKI, AKD and CKD -- Stages of CKD � including proteinuria -- The meaning of �stability� in an eGFR graph � variation over time -- Cases -- Section 1: Acute kidney injury � changes over 50% drop, assuming no asymmetry) -- Recurrent AKI leading to CKD -- Section 2: AKD � changes >48 hours 3months -- Patterns of progression � Linear and Non-linear -- Monitoring response to treatment � e.g. immunosuppression for GN, BP control in malignant hypertension -- Section 4: CKD � changes over years -- non-progressive (stable) CKD� - e.g. obstructive uropathy -- progressive CKD � e.g. transplant nephropathy, lithium nephrotoxicity, role of proteinuria as risk marker -- Use of graphs to plan future renal replacement therapy � e.g. linear progression in ADPKD -- Section 5: Acute-on-chronic kidney disease -- Chronic slowly progressive diabetic nephropathy with superimposed acute pathology, e.g. response to ACEI/ARB, contrast nephropathy, glomerulonephritis, interstitial nephritis -- Transplant rejection -- Pregnancy in women with CKD -- Section 6: Nephrotic syndrome -- GFR, serum albumin and urinary PCR graphs � use to monitor treatment and relapses, and to plan treatment -- Section 7: Other graphs -- 24 hour BP measurement � importance of nocturnal dip and timing of antihypertensives in CKD care -- Diabetes mellitus - HbA1c � colour coding as patient education tool; role of glucose control in preventing diabetic nephropathy (but no impact once CKD established) -- Serum free light chains and myeloma kidney/light chain nephropathy/immune GN -- Conclusions -- eGFR graphs � an essential tool in patient assessment which tells the story of kidney disease -- The role of graphs (eGFR, 24 hour BP, and HbA1c) in patient education and support of self-management -- Role of eGFR graphs in systematic CKD surveillance by renal units and pathology labs � evidence of benefit. | |
| 520 | 3 | _aThis book provides the essential understanding needed for the assessment of patients with kidney disease. The chapters follow the sequence taken during a clinic consultation and when clerking a patient. At each stage, the principles and concepts underlying aspects of renal medicine that may seem difficult are clearly explained. Understanding Kidney Diseases�includes numerous case studies and charts based upon patients� data to help students, residents and fellows develop their knowledge and skill in managing patients. | |
| 710 | 2 |
_aSpringerLink (Online service) _0Local _9106996 |
|
| 942 |
_2lcc _cLE |
||
| 650 | 7 |
_aMedicina _0comprobar BNE19900959047 _2embne _9405021 |
|
| 650 | 7 |
_aNefrología _0comprobar BNE19901036213 _2embne _9143254 |
|
| 700 | 1 |
_aThomas, Mark. _926997 _0comprobar BNE19984142034 |
|
| 700 | 1 |
_aMilford, David. _997513 _0Local |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-23458-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 901 | _ai9783319234588 | ||
| 907 |
_a.b1294208x _b10-10-17 _c21-11-16 |
||
| 988 | _aSpringer_Medicine_2016 | ||
| 998 |
_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0 |
||
| 945 |
_aRC902 .R396 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11586448 _z06-04-17 |
||
| 999 |
_c84930 _d84930 _x1 |
||